GFP
ARGS

Gryphon Financial Partners’s Argos Therapeutics, Inc. ARGS Stock Holding History

Gryphon Financial Partners’s Portfolio ARGS Stock Details ARGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-50
Closed – – 1042
2018
Q1 		$0 Hold
50
– – ﹤0.01% 1077
2017
Q4 		$0 Buy
+50
New – ﹤0.01% 1040